A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium

Lymphatic Research and Biology

Volumn 10, Issue 4, 2012, Pages 173-181

  Safuan, Sabreena ^a   Storr, Sarah J ^a   Patel, Poulam M ^a   Martin, Stewart G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL ASSAY; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPH VESSEL ENDOTHELIUM; MELANOMA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MCF-7 CELLS; MELANOMA; MICROSCOPY, PHASE-CONTRAST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871267547     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2012.0007     Document Type: Article

References (46)

1. Leber M, Efferth T. Molecular principles of cancer invasion and metastasis (Review). Intl J of Oncol 2009;34:881-895.
2. Mohammed R, Martin S, Muhammad S, Gill MS, Green AR, Paish EC, Ellis IO. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 2007;31: 1825-1833.
3. Storr SJ, Safuan S,MitraA, Elliott F,Walker C,VaskoMJ,Ho B, Cook M, Mohammed RA, Patel PM, Ellis IO, Newton-Bishop JA, Martin SG. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma. Mod Pathol 2012;25:493-504.
4. Oliver G, Detmar M. The rediscovery of the lymphatic system: Old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 2002; 16:773-783.
5. Johnson LA, Jackson DG. Cell traffic and the lymphatic endothelium. Ann NY Acad Sci 2008;1131:119-133.
6. Incardona F, Lewalle J, Morandi V, Lambert S, Legrand Y, Goidart JM, Legrand C. Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res 1995;55:166-173.
7. Nizamutdinova I, Lee, GW, Lee JS, Cho MK, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JS, Seo HG, Chang KC, Kim1 HJ. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 2008;29:1885-1892.
8. Yuan K, Kucik, D, Singh RK, Listinsky CM, Listinsky JJ, Siegal GP. Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties. Int J Oncol 2008;32:797-807.
9. Gout SP, Morin C, Houle F, Huot J. Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 2006;66:9117-9124.
10. Santoso S OV, Song K, Sachs UJ, Andrei-Selmer CL, Chavakis T. The homophilic binding of junctional adhesion molecule C mediates tumour cell-endothelial cell interactions. J Biol Chem 2005;280:36326-36333.
11. Kim SJ, Kim NS, Lee JL. Effect of cytokines on the expression of cell adhesion molecule and on the adhesion of melanoma cells to endothelial cells. J Korean Med Sci 1993;8:41-52.
12. ten Kate M, Hofland, LJ, Koetsveld PM, Jeekel J, Eijck CHJ. Pro-inflammatory cytokines affect pancreatic carcinoma cellendothelial cell interactions. J Pancreas 2006;7:454-464.
13. Saalbach A, Wetzel A, Haustein U-F, Sticherling M, Simon JC, Anderegg U. Interaction of human Thy-1 (CD 90) with the integrin [alpha]v[beta]3 (CD51//CD61): An important mechanism mediating melanoma cell adhesion to activated endothelium. Oncogene 2005;24:4710-4720.
14. Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud K, Tonra JR, Witte L, Alitalo K. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 2007;67:593-599.
15. Banerji S, Ni J, Wang S-X, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
16. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-1513.
17. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005;166:913-921.
18. Kahn HJ, Alexander M. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002;82:1255-1257.
19. Kawai Y, Kaidoh, M, Yokoyama Y, Sano K, Ohhashi T. Chemokine CCL2 facilitates ICAM-1-mediated interactions of cancer cells and lymphatic endothelial cells in sentinel lymph nodes. Cancer Sci 2009;100:419-428.
20. Danussi C, Coslovi A, Campa C, Mucignat MT, Spessotto P, Uggeri F, Paoletti S, Colombatti A. A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction. 2009;19:1056-1067.
21. Jaffe E, Nachman R, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
22. Matsuo M, Koizumi, K, Yamada S, Tomi M, Takahashi R, Ueda M, Terasaki T, Obinata M, Hosoya K, Ohtani O, Saiki I. Establishment and characterization of conditionally immortalized endothelial cell lines from the thoracic duct and inferior vena cava of tsA58/EGFP double-transgenic rats. Cell Tissue Res 2006;326:749-758.
23. Nisato RE, Harrison JA, Buser R, Orci L, Rinsch C,Montesano R, Dupraz P, Pepper MS. Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span. Am J Pathol 2004;165:11-24.
24. Sheikh S, Gale Z, Rainger GE, Nash GB. Methods for exposing multiple cultures of endothelial cells to different fluid shear stresses and to cytokines, for subsequent analysis of inflammatory function. J Immunol Methods 2004;288:35-46.
25. Liang C-C, Park AY, Guan J-L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocols 2007;2:329-333.
26. Salmi M, Koskinen K, Henttinen T, Elima K, Jalkanen S. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 2004;104:3849-3857.
27. van Grevenstein W, Hofland, LJ, van Rossen MEE, van Koetsveld PM, Jeekel J, van Eijck CHJ. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci 2007;52:2775-2783.
28. Sun W, Pitson SM, Bonder CS. Tumour necrosis factorinduced neutrophil adhesion occurs via sphingosine kinease-1 dependent activation of endothelial a5b1 integrin. Am J Pathol 2010;177:436-446.
29. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006;2763-2777.
30. Eccles SA, Welch DR. Metastasis: Recent discoveries and novel treatment strategies. Lancet 2007;369:1742-1757.
31. Walter-Yohrling J CX, Callahan M, Weber W, Morgenbesser S, Madden SL, Wang C, Teicher BA. Identification of genes expressed in malignant cells that promote invasion. Cancer Res 2003;63:8939-8947.
32. Kim H, Kim, JY, Han EH, Hwang YP, Choi JH, Park BH, Jeong HG. Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS Lett 2010;585:421-428.
33. Kuroda H, Nakai M, Ohnisi K, Ishida T, Kuroda M, Itoyama S. Vascular invasion in triple-negative carcinoma of the breast identified by endothelial lymphatic and blood vessel marker. Int J Surg Pathol 2010;18:324-329.
34. Doeden K, Ma Z, Narasimhan B, Swetter SM, Detmar M, Dadras SS. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. J Cut Pathol 2009;36:772-780.
35. Swerlick R, Lee, KH, Li LJ, Sepp NT, Caughman SW, Lawley TJ. Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992;149:698-705.
36. Murakami S, Morioka, T, Nakagawa Y, Suzuki Y, Arakawa M, Olte T. Expression of adhesion molecule by cultures human glomerular endothelial cells in response to cytokines: Comparison to human umbilical vein and dermal microvascular endothelial cells. Microvasc Res 2001;62:282-291.
37. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003;10:45-65.
38. Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002;296: 1634-1635.
39. Voura EB, Sandig M, Kalnins VI, Siu C. Cell shape changes and cytoskeleton reorganization during transendothelial migration of human melanoma cells. Cell Tissue Res 1998;293:375-387.
40. Choo M, Sakurai, H, Koizumi K, Saiki I. TAK1-mediated stress signaling pathways are essential for TNF-alphapromoted pulmonary metastasis of murine colon cancer cells. Int J Cancer 2006;118:2758-2764.
41. Katerinaki E, Evans, GS, Lorigan PC, MacNeil S. TNF-a increases human melanoma cell invasion and migration in vitro: The role of proteolytic enzymes. Br J Cancer 2003;89:1123-1129.
42. Liang M, Zhang P, Fu J. Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDAMB- 231 breast cancer cells. Cancer Lett 2007;258:31-37.
43. Wang X, Yong L. Tumor necrosis factor and cancer, buddies or foes. Acta Pharmacol Sin 2008;29:1275-1288.
44. Hidalgo K, Rojas I, Penissi AB, Rudolph MI. TNF-a increases in vitro migration of human HPV18-positive SW756 cervical carcinoma cells. Biocell 2005;29:303-311.
45. Morandini R, Boeynaems, JM, Hedley SJ, MacNeil S, Ghanem G. Modulation of ICAM-1 expression by alpha-MSH in human melanoma cells and melanocytes. J Cell Physiol 1998;175: 276-282.
46. Zhu N, Eves, PC, Katerinaki E, Szabo M, Morandini R, Ghanem G, Lorigan P, MacNeil S, Haycock J. Melanoma cell attachment, invasion and integrin expression is upregulated by tumour necrosis factor-a and suppressed by a-melanocyte stimulating hormone. J Invest Dermatol 2002;119:1165-1171.